Isotretinoin treatment of Sebaceous Hyperplasia (SH) in Organ Transplant Recipients (OTRs) – case reports and literature review
Case Reports in Dermatology · 29.10.2026
DOI: 10.1159/cde/abvag034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Case Reports in Dermatology, online erschienen am 29.10.2026. Verfasst von Joanna Górak und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Sebaceous Hyperplasia (SH) is a benign skin condition involving enlarged sebaceous glands, commonly observed in Organ Transplant Recipients (OTRs) due to long-term immunosuppressive therapy. Drugs such as Cyclosporine (CsA) and Tacrolimus (TAC) are strongly associated with the development of SH [1-3]. The article presents three cases where low-dose of oral isotretinoin was used to successfully treat SH in renal transplant patients. Treatment resulted in significant clinical improvement without adverse effects on graft function or overall health. Patients tolerated the therapy well, and no organ rejection or deterioration in renal parameters was observed. These findings suggest isotretinoin may be a safe and effective option for managing SH in this population. However, larger, controlled studies are needed to confirm these outcomes and support the development of standardized treatment protocols [1-3].
Zitieren
APA
Górak, J., Chojnowska, M., Debska-Slizien, A., & Imko-Walczuk, B. (2026). Isotretinoin treatment of Sebaceous Hyperplasia (SH) in Organ Transplant Recipients (OTRs) – case reports and literature review. Case Reports in Dermatology. https://doi.org/10.1159/cde/abvag034
Vancouver
Górak J, Chojnowska M, Debska-Slizien A, Imko-Walczuk B. Isotretinoin treatment of Sebaceous Hyperplasia (SH) in Organ Transplant Recipients (OTRs) – case reports and literature review. Case Reports in Dermatology. 2026. doi:10.1159/cde/abvag034
BibTeX
@article{Grak2026,
author = {Górak, Joanna and Chojnowska, Marta and Debska-Slizien, Alicja and Imko-Walczuk, Beata},
title = {Isotretinoin treatment of Sebaceous Hyperplasia (SH) in Organ Transplant Recipients (OTRs) – case reports and literature review},
journal = {Case Reports in Dermatology},
year = {2026},
doi = {10.1159/cde/abvag034}
}
EUVIMED